The Use of Low-Dose Naltrexone for Chronic Pain

Area of Science:

• Pharmacology
• Pain Management
• Immunology

Background:

• Chronic pain affects millions globally, with current treatments often associated with significant side effects.
• Nonopioid alternatives for chronic pain management are urgently needed.
• Low-dose naltrexone (LDN) is an oral formulation of naltrexone at 1 mg to 4.5 mg daily.

Purpose of the Study:

• To evaluate the potential of low-dose naltrexone as a novel treatment for chronic pain.
• To compare the efficacy and safety profile of LDN with existing pain management strategies.
• To highlight LDN as a viable, nonopioid therapeutic option.

Main Methods:

• Review of existing literature on low-dose naltrexone (LDN) use in chronic pain.
• Analysis of LDN's mechanism of action and clinical applications.
• Comparison of adverse effect profiles between LDN and conventional pain medications.

Main Results:

• Low-dose naltrexone is effective for managing chronic pain, autoimmune disorders, and dermatologic conditions.
• LDN exhibits a favorable safety profile with minimal adverse effects and no reported drug-drug interactions.
• LDN is a cost-effective treatment option compared to other pain management modalities.

Conclusions:

• Low-dose naltrexone represents a promising, nonopioid therapeutic strategy for chronic pain.
• LDN's efficacy, safety, and affordability position it as a valuable alternative to conventional treatments.
• Further clinical research is warranted to fully elucidate LDN's role in pain management.